Physician profile
Whitney W Stevens
NPI 1952622649
$34,192.12
in general payments reported to CMS, 2019-2025
9 companies · $282 in 2025
The $282 reported for 2025 was less than what a typical Allergy & Immunology provider received nationally (typical 2025 total: $1,138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,403 · 2020: $8,625 · 2021: $6,500 · 2022: $7,157 · 2023: $2,924 · 2024: $1,300 · 2025: $282.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $4,100 · Food and Beverage: $407.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $4,100.00 |
| Food and Beverage | $406.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $18,550.77 | 2019-2025 | Nucala |
| Regeneron Pharmaceuticals, INC. | $6,523.00 | 2022 | |
| Melinta Therapeutics, LLC | $2,800.00 | 2023 | Orbactiv, Kimyrsa |
| Genentech, INC. | $2,775.00 | 2020 | |
| Celgene Corporation | $2,600.00 | 2020 | |
| Genzyme Corporation | $536.38 | 2022-2025 | |
| Astrazeneca Pharmaceuticals Lp | $168.39 | 2022-2025 | |
| Regeneron Healthcare Solutions, INC. | $124.21 | 2023 | Dupixent |
| Blueprint Medicines Corporation | $114.37 | 2025 | Ayvakit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Whitney Stevens listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.